Stay informed with the latest updates for the inheritable blood disorders community. NBDF & Community Calling All Men Age 50+ Living with HemophiliaDec 27, 2016 Industry Octapharma Reports Data on Inhibitor Rates in Nuwiq® Trial Dec 22, 2016 Medical New Medscape Activity on Adolescents and SportsDec 21, 2016 Industry UniQure’s Hemophilia B Gene Therapy Performs Well in Clinical TrialDec 19, 2016 Advocacy & Legislative CMS Cancels Controversial Medicare Part B DemoDec 16, 2016 Industry CSL Behring Presents Data on Therapeutic Potential of Idelvion® Dec 15, 2016 NBDF & Community …Dec 15, 2016 Industry Biogen Reports ELOCTATE™ Shows Positive Implications for Quality of LifeDec 14, 2016 Industry Alnylam Reports Progress on Investigational Subcutaneous Hemophilia…Dec 13, 2016 NBDF & Community NHF Attends First European Inhibitor SummitDec 12, 2016 NBDF & Community Message from Val Bias Regarding HIV/AIDS MemorialDec 8, 2016 Advocacy & Legislative Planning to Renew or Enroll in the Healthcare Marketplace for 2017? Dec 7, 2016 Industry Sangamo Reports Hemophilia A Gene Therapy Progress at ASHDec 7, 2016 Industry Spark Reports Positive Data from Hemophilia B Gene Therapy ProgramDec 7, 2016 Medical Medscape Activity Focuses on Joint HealthDec 7, 2016 Pagination First page Previous page … Page 55 Page 56 Page 57 Page 58 Current page 59 Page 60 Page 61 Page 62 Page 63 … Next page Last page